{"id":15665,"date":"2023-11-21T15:31:39","date_gmt":"2023-11-21T14:31:39","guid":{"rendered":"https:\/\/udic.es\/?p=15665"},"modified":"2024-02-14T19:34:36","modified_gmt":"2024-02-14T18:34:36","slug":"una-opcion-de-modificar-el-curso-progresivo-del-parkinson","status":"publish","type":"post","link":"https:\/\/udic.es\/ca\/una-opcion-de-modificar-el-curso-progresivo-del-parkinson\/","title":{"rendered":"Una opci\u00f3 de modificar el curs progressiu del Parkinson"},"content":{"rendered":"
Avaluem un inhibidor del gen LRRK 2 en pacients amb Parkinson. Tractament oral.
\nContinuem el desenvolupament de nous tractaments que pretenen modificar la hist\u00f2ria natural de la malaltia, enlentint la seva progressi\u00f3.
\nUna opci\u00f3 de modificar el curs progressiu del Parkinson<\/p>\n","protected":false},"excerpt":{"rendered":"
Avaluem un inhibidor del gen LRRK 2 en pacients amb Parkinson. Tractament oral. Continuem el desenvolupament de nous tractaments que pretenen modificar la hist\u00f2ria natural de la malaltia, enlentint la seva progressi\u00f3. Una opci\u00f3 de modificar el curs progressiu del Parkinson<\/p>\n","protected":false},"author":5,"featured_media":9250,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[106],"tags":[],"class_list":["post-15665","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alzeimer-ca"],"yoast_head":"\n